RECRUITING

Arrhythmia Detection After MI

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Patients post acute myocardial infarction (AMI) have a high risk of mortality but the use of an implantable defibrillator in the early aftermath of an AMI has not been shown to improve patients' survival. The VEST trial recently demonstrated an improved overall survival in post AMI patients with the use of a wearable defibrillator. The same improvement was not demonstrated for the risk of sudden cardiac death. Monitoring patients after AMI using an implantable cardiac monitor (ICM) may document findings that can impact patient management and eventually improve their outcomes. We are therefore conducting the AID MI trial to examine the impact of ICM on patient management in the post AMI setting.

Official Title

Arrhythmia Detection After Myocardial Infarction Trial

Quick Facts

Study Start:2022-08-09
Study Completion:2025-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05073419

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults, age 18 years or older
  2. * AMI (STEMI and NSTEMI)
  3. * Willing to give written informed consent
  4. * Expected discharge from hospital within 7 days of AMI
  5. * Willing to receive ICM insertion within 21 days of index AMI
  1. * Existing pacemaker, ICD, ICM, or any other implantable cardiac electronic device
  2. * Pregnant
  3. * Index AMI was more than 21 days
  4. * Unwilling/cannot insert ICM within 21 days post AMI
  5. * Planned ICD implant, planned CABG or any open-heart surgery (e.g. for severe valvular disease)

Contacts and Locations

Study Contact

Samir F Saba, MD
CONTACT
412 647 2695
sabas@upmc.edu
Melissa Enlow
CONTACT
412-647-1582
enlowms@upmc.edu

Principal Investigator

Samir F Saba, MD
PRINCIPAL_INVESTIGATOR
University of Pittsburgh Medical Center

Study Locations (Sites)

UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania, 15213
United States

Collaborators and Investigators

Sponsor: Samir Saba

  • Samir F Saba, MD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-08-09
Study Completion Date2025-10

Study Record Updates

Study Start Date2022-08-09
Study Completion Date2025-10

Terms related to this study

Additional Relevant MeSH Terms

  • Acute Myocardial Infarction